0001779735-21-000001.txt : 20210802 0001779735-21-000001.hdr.sgml : 20210802 20210802150632 ACCESSION NUMBER: 0001779735-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210802 DATE AS OF CHANGE: 20210802 EFFECTIVENESS DATE: 20210802 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vascular Perfusion Solutions, Inc. CENTRAL INDEX KEY: 0001779735 IRS NUMBER: 813798785 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-408486 FILM NUMBER: 211135694 BUSINESS ADDRESS: STREET 1: 503 AVENUE A, SUITE 1115 CITY: SAN ANTONIO STATE: TX ZIP: 78215 BUSINESS PHONE: 210-977-0191 MAIL ADDRESS: STREET 1: 503 AVENUE A, SUITE 1115 CITY: SAN ANTONIO STATE: TX ZIP: 78215 D 1 primary_doc.xml X0708 D LIVE 0001779735 Vascular Perfusion Solutions, Inc. 312 Pearl Parkway Building 5, Suite 5104 SAN ANTONIO TX TEXAS 78215 210-977-0191 DELAWARE None None Corporation true 2016 Tom DeBrooke 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Executive Officer Director Leon Bunegin 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Executive Officer Director Mark Muller 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Executive Officer Director Klaus Weiswurm 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Director Celia Jairala 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Director Paul Perry 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Executive Officer Biotechnology Decline to Disclose 06b false 2021-07-20 false true Debt convertible into equity false 0 3000000 1050000 1950000 false 3 0 0 0 A portion of the proceeds will be used to pay compensation to some of the Executive Officers named in response to item 3 above. false Vascular Perfusion Solutions, Inc. Tom DeBrooke Tom DeBrooke CEO 2021-08-02